What it is
Tesamorelin is a growth-hormone-releasing hormone analogue. It has formal human trial data and an approved use aimed at reducing excess visceral abdominal fat in adults with HIV-associated lipodystrophy. That indication is specific. It is not a general fat-loss approval. Confirm the current label with a licensed prescriber before treating any wording here as the last word.
Studied for
- Reducing excess visceral fat in the specific population named on its label.
- The growth-hormone axis, which is the pathway the trials measured.
The evidence
Human trial. The record here is a formal drug programme with measured human outcomes, not a gym protocol. The approval does not extend itself to every goal people bring to a growth-hormone conversation.
What this page will not do
- We will not restate this as a cosmetic fat-loss plan.
- We do not give doses or hormone-axis targets.
- Anything hormone-adjacent belongs with a physician who can order and read the right labs.
Still open
- Whether the labeled indication matches the question you actually have.
- What the current label says this month — labels change, and this page is not the label.
Educational content only. This page does not diagnose, treat, cure, or prevent anything, and it is not a dose. Talk with a licensed physician before starting, stopping, or changing any medication. Library reviewed November 2026.